Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

However, there are some ways to diagnose FTD including scans and genetic testing. Frontotemporal dementia (FTD) Who gets frontotemporal dementia? You are here: Getting a diagnosis of frontotemporal ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Objective To conduct a scoping review of the literature on apathy in Parkinson’s disease (PD), to better understand how apathy in Parkinson’s disease is diagnosed, treated and managed. Methods MEDLINE ...

Dr Balanson, who lived in San Diego before moving to Sydney, was diagnosed with Parkinson's 15 years ago. "The knowledge base of the general population having the disease (back then) was quite ...